Total Payments
$22,579
2024 Payments
$3,283
Companies
76
Transactions
883
Medicare Patients
4,355
Medicare Billing
$386,921
Payment Breakdown by Category
Food & Beverage$20,635 (91.4%)
Consulting$1,200 (5.3%)
Other$618.42 (2.7%)
Education$125.41 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,635 | 875 | 91.4% |
| Consulting Fee | $1,200 | 1 | 5.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $350.00 | 1 | 1.6% |
| Debt forgiveness | $268.42 | 2 | 1.2% |
| Education | $125.41 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,080 | 128 | $0 (2024) |
| Novo Nordisk Inc | $2,240 | 110 | $0 (2024) |
| ABBVIE INC. | $1,785 | 114 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,513 | 11 | $0 (2021) |
| Amgen Inc. | $1,394 | 34 | $0 (2024) |
| Lilly USA, LLC | $1,212 | 71 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,002 | 35 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $849.06 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $800.37 | 36 | $0 (2024) |
| Abbott Laboratories | $583.96 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,283 | 121 | AstraZeneca Pharmaceuticals LP ($657.75) |
| 2023 | $3,670 | 130 | Amgen Inc. ($671.84) |
| 2022 | $2,786 | 124 | ABBVIE INC. ($557.45) |
| 2021 | $5,209 | 179 | Biohaven Pharmaceuticals, Inc. ($1,424) |
| 2020 | $2,188 | 122 | AstraZeneca Pharmaceuticals LP ($396.41) |
| 2019 | $1,936 | 84 | AstraZeneca Pharmaceuticals LP ($602.08) |
| 2018 | $1,951 | 67 | AstraZeneca Pharmaceuticals LP ($787.17) |
| 2017 | $1,555 | 56 | SANOFI-AVENTIS U.S. LLC ($499.90) |
All Payment Transactions
883 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $76.50 | General |
| Category: EndoVenous Therapies | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Bone Health | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $111.74 | General |
| Category: Insomnia | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,159 | 1,913 | $409,786 | $109,440 |
| 2022 | 23 | 1,143 | 1,680 | $360,958 | $101,142 |
| 2021 | 19 | 1,153 | 1,642 | $361,012 | $106,735 |
| 2020 | 18 | 900 | 1,295 | $193,978 | $69,603 |
Total Patients
4,355
Total Services
6,530
Medicare Billing
$386,921
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 286 | 682 | $158,906 | $38,819 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 315 | $104,265 | $26,218 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $59,312 | $22,478 | 37.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 85 | $10,965 | $3,164 | 28.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 80 | $12,960 | $3,108 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,928 | $2,619 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $12,012 | $2,551 | 21.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 15 | $7,890 | $2,330 | 29.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,148 | $1,811 | 35.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 16 | 19 | $5,624 | $1,442 | 25.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 25 | 31 | $3,193 | $1,217 | 38.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 31 | 41 | $3,567 | $1,058 | 29.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 106 | 110 | $4,180 | $984.41 | 23.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 17 | 17 | $1,955 | $535.74 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $1,430 | $336.93 | 23.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 35 | $1,295 | $326.82 | 25.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 90 | 112 | $2,800 | $246.40 | 8.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 38 | 40 | $520.00 | $99.90 | 19.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 16 | 22 | $836.00 | $93.89 | 11.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 40 | $1,000 | $2.42 | 0.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 605 | $140,965 | $34,430 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 161 | 276 | $91,356 | $25,247 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 159 | 159 | $53,583 | $21,003 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $12,354 | $3,165 | 25.6% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 11 | 11 | $7,854 | $2,470 | 31.5% |
About Dr. Sam Abraham, MD
Dr. Sam Abraham, MD is a Internal Medicine healthcare provider based in Richardson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1831349448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Abraham, MD has received a total of $22,579 in payments from pharmaceutical and medical device companies, with $3,283 received in 2024. These payments were reported across 883 transactions from 76 companies. The most common payment nature is "Food and Beverage" ($20,635).
As a Medicare-enrolled provider, Abraham has provided services to 4,355 Medicare beneficiaries, totaling 6,530 services with total Medicare billing of $386,921. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Richardson, TX
- Active Since 09/19/2008
- Last Updated 12/18/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831349448
Products in Payments
- FARXIGA (Drug) $2,397
- NURTEC ODT (Drug) $1,792
- VRAYLAR (Drug) $1,054
- Kerendia (Drug) $849.06
- Ozempic (Drug) $827.84
- BREZTRI (Drug) $559.13
- SOLIQUA (Drug) $517.53
- UBRELVY (Drug) $512.34
- Vascepa (Drug) $482.77
- TRULICITY (Drug) $450.44
- MOUNJARO (Drug) $449.85
- BYDUREON (Drug) $438.24
- EVENITY (Biological) $437.53
- TRELEGY ELLIPTA (Drug) $425.90
- SOLIQUA 100/33 (Biological) $384.75
- RYBELSUS (Drug) $367.69
- AIRSUPRA (Drug) $367.67
- Otezla (Drug) $311.95
- FREESTYLE LIBRE 3 (Device) $309.59
- QULIPTA (Drug) $275.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richardson
Dr. Olusegun Oyenuga, M.d, M.D
Internal Medicine — Payments: $60,989
Internal Medicine $60,989
Dr. Atinuke Aluko, Md, MD
Internal Medicine — Payments: $40,662
Internal Medicine $40,662
Dr. Alanna Silverstein, M.d, M.D
Internal Medicine — Payments: $25,245
Internal Medicine $25,245
Dr. Allan Chernov, M.d, M.D
Internal Medicine — Payments: $22,904
Internal Medicine $22,904
Dr. Asad Mohmand, M.d, M.D
Internal Medicine — Payments: $20,721
Internal Medicine $20,721
Trung Dao, Md, MD
Internal Medicine — Payments: $18,072
Internal Medicine $18,072